ABIGAIL DEGAN: Open Payments
NPI 1144835034 · MCPHERSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 29 payments from 10 companies in 2025. Trend: 2023 $868 · 2024 $1,109 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $108 |
| Lilly USA, LLC | 5 | $81 |
| PFIZER INC. | 4 | $66 |
| ABBVIE INC. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Novo Nordisk Inc | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $19 |
| Globus Medical, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: GEMTESA, MOUNJARO, QULIPTA, NURTEC ODT, AIRSUPRA, JARDIANCE, PREVNAR 20, VOQUEZNA.
Industry payments across KS — which companies pay providers there.
